The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
Open accessAbstract
BACKGROUND: Comorbidities associated with systemic inflammation including cardiovascular disease (CVD), stroke and diabetes mellitus (DM) are common among individuals with chronic obstructive pulmonary disease (COPD). A study was undertaken to quantify the burden of comorbidity and to determine the risk of first acute arteriovascular events among individuals with COPD. METHODS: The computerised primary care records of 1,204,100 members of the general population aged ≥ 35 years on 25 February 2005 were searched for recordings of each disease. Data were analysed using multivariate logistic regression. Cox regression was used to determine whether individuals with COPD were at increased risk of acute myocardial infarction (MI) and stroke. RESULTS: Cross-sectional analyses showed that physician-diagnosed COPD was associated with increased risks of CVD (OR 4.98, 95% CI 4.85 to 5.81; p<0.001), stroke (OR 3.34, 95% CI 3.21 to 3.48; p<0.001) and DM (OR 2.04, 95% CI 1.97 to 2.12; p<0.001). In the follow-up analyses, after adjusting for confounding by sex and smoking status and stratifying for age, the greatest increase in the rate of acute arteriovascular events was found in the youngest age groups; the HR for acute MI was 10.34 (95% CI 3.28 to 32.60; p<0.001) and for stroke the HR was 3.44 (95% CI 0.85 to 13.84; p<0.001) compared with the oldest age group. CONCLUSION: Individuals with COPD are substantially more likely to have pre-existing CVD, DM or a previous stroke and are at high risk of acute arteriovascular events. National COPD guidelines and models of care need to adapt to provide an integrated approach to addressing these comorbidities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
(2003) · RePEc: Research Papers in Economics · Cited by 1,844
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C. L., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 911
From COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Pulmonary Function Is a Long-term Predictor of Mortality in the General Population
Schu¨nemann, H. J., Dorn, J., Grant, B. J. B., Winkelstein, W., & Trevisan, M. (2000) · Chest · doi:10.1378/chest.118.3.656 · Cited by 590
Hospitalizations and Mortality in the Lung Health Study
Anthonisen, N. R., Connett, J. E., Enright, P. L., & Manfreda, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110093 · Cited by 588
Cited by
Vanfleteren, L. E. G. W., Spruit, M. A., Groenen, M., Gaffron, S., van Empel, V. P. M., Bruijnzeel, P. L. B., Rutten, E. P. A., Op ’t Roodt, J., Wouters, E. F. M., & Franssen, F. M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1665oc · Cited by 828
Chen, W., Thomas, J., Sadatsafavi, M., & FitzGerald, J. M. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00241-6 · Cited by 718
Cavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
Miller, J., Edwards, L. D., Agustí, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., Miller, B. E., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.05.001 · Cited by 437
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s49621 · Cited by 407
Cardiovascular Comorbidity in COPD
Müllerova, H., Agusti, A., Erqou, S., & Mapel, D. W. (2013) · Chest · doi:10.1378/chest.12-2847 · Cited by 358
Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Morgan, A. D., Zakeri, R., & Quint, J. K. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465817750524 · Cited by 337
Nowakowska, M., Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C., Van Marwijk, H., Peek, N., Perera-Salazar, R., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1373-y · Cited by 330
Chronic obstructive pulmonary disease and comorbidities
Decramer, M., & Janssens, W. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(12)70060-7 · Cited by 291
King, P. T. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0068-z · Cited by 269
Metadata
- Authors
- Feary, J. R., Rodrigues, L. C., Smith, C. J., Hubbard, R. B., & Gibson, J. E.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2010-09-25
- Volume
- 65
- Issue
- 11
- Pages
- 956-962
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2111722183
- Cited by
- 445
- References
- 28
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.